Literature DB >> 15638863

Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia.

Vikki G Nolan1, Clinton Baldwin, Qianli Ma, Diego F Wyszynski, Yvonne Amirault, John J Farrell, Alice Bisbee, Stephen H Embury, Lindsay A Farrer, Martin H Steinberg.   

Abstract

The complications of sickle cell disease are probably determined by genes whose products modify the pathophysiology initiated by the sickle haemoglobin mutation. Priapism, one vaso-occlusive manifestation of sickle cell disease, affects more than 30% of males with the disease. We examined the possible association of single nucleotide polymorphisms (SNPs) in 44 candidate genes of different functional classes for an association with the occurrence of priapism. One hundred and forty-eight patients with sickle cell anaemia and incident or a confirmed history of priapism were studied, along with 529 controls that had not developed priapism. Polymorphisms in the KLOTHO gene (KL; 13q12) showed an association with priapism by genotypic [reference SNP cluster identifier number (rs)2249358; odds ratio (OR) = 2.6 (1.4-5.5); rs211239; OR = 1.7 (1.2-2.6)] and haplotype analyses [rs211234 and rs211239; OR = 2.3 (1.5-3.4)]. These findings may have broader implications in sickle cell disease, as KL encodes a membrane protein that regulates many vascular functions, including vascular endothelial growth factor expression and endothelial nitric oxide release.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15638863     DOI: 10.1111/j.1365-2141.2004.05295.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  34 in total

1.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Johanne Pastor; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque; Kevin P Rosenblatt; Michel G Baum; Makoto Kuro-o; Orson W Moe
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

Review 2.  Genetic modifiers of sickle cell disease.

Authors:  Martin H Steinberg; Paola Sebastiani
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

Review 3.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

4.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

5.  Leg ulcers in sickle cell disease.

Authors:  Caterina P Minniti; James Eckman; Paola Sebastiani; Martin H Steinberg; Samir K Ballas
Journal:  Am J Hematol       Date:  2010-10       Impact factor: 10.047

6.  Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

7.  The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.

Authors:  Megan L Krajewski; Lewis L Hsu; Mark T Gladwin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

8.  Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Authors:  Tracey B Tucker Zhou; Gwendalyn D King; CiDi Chen; Carmela R Abraham
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

Review 9.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

10.  Sodium nitrite promotes regional blood flow in patients with sickle cell disease: a phase I/II study.

Authors:  A Kyle Mack; Vicki R McGowan Ii; Carole K Tremonti; Diana Ackah; Christopher Barnett; Roberto F Machado; Mark T Gladwin; Gregory J Kato
Journal:  Br J Haematol       Date:  2008-07-11       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.